Tonix Pharmaceuticals Relocates Offices, Updates Contact Info
Ticker: TNXP · Form: 8-K · Filed: Jul 9, 2025 · CIK: 1430306
Sentiment: neutral
Topics: administrative-update, office-relocation
Related Tickers: TNXP
TL;DR
TNXP moved offices and updated their phone number. Check the new address.
AI Summary
Tonix Pharmaceuticals Holding Corp. filed an 8-K on July 9, 2025, reporting on other events and financial statements. The filing indicates a change in the company's principal executive offices to 26 Main Street, Suite 101, Chatham, New Jersey, 07928. The company's telephone number has also been updated to (862) 799-8599.
Why It Matters
This filing signals operational changes for Tonix Pharmaceuticals, potentially impacting logistics, investor relations, and employee location.
Risk Assessment
Risk Level: low — The filing primarily concerns administrative changes like office relocation and contact information updates, which typically carry low risk.
Key Players & Entities
- Tonix Pharmaceuticals Holding Corp. (company) — Registrant
- July 9, 2025 (date) — Filing Date
- 26 Main Street, Suite 101, Chatham, New Jersey, 07928 (location) — New Principal Executive Offices
- (862) 799-8599 (phone_number) — Updated Registrant Telephone Number
FAQ
What is the new address for Tonix Pharmaceuticals Holding Corp.'s principal executive offices?
The new address is 26 Main Street, Suite 101, Chatham, New Jersey, 07928.
What is the updated telephone number for Tonix Pharmaceuticals Holding Corp.?
The updated telephone number is (862) 799-8599.
On what date was this 8-K filing submitted?
This 8-K filing was submitted on July 9, 2025.
What is the Commission File Number for Tonix Pharmaceuticals Holding Corp.?
The Commission File Number is 001-36019.
In which state is Tonix Pharmaceuticals Holding Corp. incorporated?
Tonix Pharmaceuticals Holding Corp. is incorporated in Nevada.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 9, 2025 regarding Tonix Pharmaceuticals Holding Corp. (TNXP).